PATENT CLAIM ANALYSIS

Application Number: 15746335
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "007100"]

Abstract:
The invention provides a process for analysis of the presence of atherosclerosis in a patient sample, and preferably identifies a form of atherosclerosis that correlates to an increased risk of the patient to develop rheumatoid arthritis (RA), connective tissue diseases, vasculitis, and/or spondyloarthritis, and/or myocardial infarction and/or apoplexy.

Claim (Index 5):
Process according to  claim 1 , wherein atherosclerosis and/or an increased risk for myocardial infarction and/or apoplexy is determined for a concentration of the anti-MAZI auto-antibody in the patient sample elevated over the mean concentration of anti-MAZI auto-antibody determined in samples of an arbitrary group of persons, or in samples from persons who are diagnosed as being free from atherosclerosis, rheumatoid arthritis, rheumatoid spondylitis, connective tissue diseases, vasculitis, spondyloarthritis, myocardial infarction and/or apoplexy.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.36585
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14261843', '12376164', '12681349', '13613010', '14116924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.595626025435358
- 35 USC 102 Novelty (BERT): 0.4888988526960473
- Combined Prediction Score: 0.584953308161427
- Mean Citation Score: 200.499088
- Max Citation Score: 205.21992
- Similarity Product: 144.20273294488908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test